Literature DB >> 14534146

Designer blood vessels and therapeutic revascularization.

Joseph D Berglund1, Zorina S Galis.   

Abstract

Inadequate vascular perfusion leads to fatal heart attacks, chronic ulcers, and other serious clinical conditions. The body's capacity to restore vascular perfusion through angiogenesis and arteriogenesis is often impaired by pre-existing disease, and availability of native replacements for nonfunctional arteries is limited in many patients. Thus, recreating blood vessels of various calibres through novel engineering technologies has emerged as a radical option among therapeutic strategies for revascularization. Ranging from artificial, recycled or reassembled natural conduits to sophisticated microdevices, we refer to these as 'designer blood vessels'. Our common efforts to continuously improve vascular replacement design have provided many clues about our own blood vessels, but nature's ability to create nonthrombogenic, immunocompatible, strong, yet biologically responsive blood vessels remains unparalleled. Just as art reproductions never equal the original masterpiece, designer blood vessels may never attain nature's perfection. Nevertheless, they will provide a valuable option as long as they come close enough and are available to many.

Entities:  

Mesh:

Year:  2003        PMID: 14534146      PMCID: PMC1574062          DOI: 10.1038/sj.bjp.0705457

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  75 in total

Review 1.  Patterning proteins and cells using soft lithography.

Authors:  R S Kane; S Takayama; E Ostuni; D E Ingber; G M Whitesides
Journal:  Biomaterials       Date:  1999-12       Impact factor: 12.479

2.  Using microcontact printing to pattern the attachment of mammalian cells to self-assembled monolayers of alkanethiolates on transparent films of gold and silver.

Authors:  M Mrksich; L E Dike; J Tien; D E Ingber; G M Whitesides
Journal:  Exp Cell Res       Date:  1997-09-15       Impact factor: 3.905

3.  In vitro construction of a human blood vessel from cultured vascular cells: a morphologic study.

Authors:  N L'Heureux; L Germain; R Labbé; F A Auger
Journal:  J Vasc Surg       Date:  1993-03       Impact factor: 4.268

4.  Mechanical stress induced cellular orientation and phenotypic modulation of 3-D cultured smooth muscle cells.

Authors:  K Kanda; T Matsuda; T Oka
Journal:  ASAIO J       Date:  1993 Jul-Sep       Impact factor: 2.872

Review 5.  Small intestinal submucosa as a vascular graft: a review.

Authors:  G C Lantz; S F Badylak; M C Hiles; A C Coffey; L A Geddes; K Kokini; G E Sandusky; R J Morff
Journal:  J Invest Surg       Date:  1993 May-Jun       Impact factor: 2.533

6.  The role of matrix metalloproteinase-2 in the remodeling of cell-seeded vascular constructs subjected to cyclic strain.

Authors:  D Seliktar; R M Nerem; Z S Galis
Journal:  Ann Biomed Eng       Date:  2001-11       Impact factor: 3.934

7.  Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease.

Authors:  T K Rosengart; L Y Lee; S R Patel; T A Sanborn; M Parikh; G W Bergman; R Hachamovitch; M Szulc; P D Kligfield; P M Okin; R T Hahn; R B Devereux; M R Post; N R Hackett; T Foster; T M Grasso; M L Lesser; O W Isom; R G Crystal
Journal:  Circulation       Date:  1999-08-03       Impact factor: 29.690

Review 8.  Engineering of vascular ingrowth matrices: are protein domains an alternative to peptides?

Authors:  C Merzkirch; N Davies; P Zilla
Journal:  Anat Rec       Date:  2001-08-01

Review 9.  Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly.

Authors:  Zorina S Galis; Jaikirshan J Khatri
Journal:  Circ Res       Date:  2002-02-22       Impact factor: 17.367

10.  VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts.

Authors:  M D Hariawala; J R Horowitz; D Esakof; D D Sheriff; D H Walter; B Keyt; J M Isner; J F Symes
Journal:  J Surg Res       Date:  1996-06       Impact factor: 2.192

View more
  10 in total

1.  Mechanistic exploration of phthalimide neovascular factor 1 using network analysis tools.

Authors:  Kristen A Wieghaus; Erwin P Gianchandani; Milton L Brown; Jason A Papin; Edward A Botchwey
Journal:  Tissue Eng       Date:  2007-10

Review 2.  Redox-dependent mechanisms in coronary collateral growth: the "redox window" hypothesis.

Authors:  June Yun; Petra Rocic; Yuh Fen Pung; Souad Belmadani; Ana Catarina Ribeiro Carrao; Vahagn Ohanyan; William M Chilian
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

3.  Expansion of microvascular networks in vivo by phthalimide neovascular factor 1 (PNF1).

Authors:  Kristen A Wieghaus; Meghan M Nickerson; Caren E Petrie Aronin; Lauren S Sefcik; Richard J Price; Mikell A Paige; Milton L Brown; Edward A Botchwey
Journal:  Biomaterials       Date:  2008-09-18       Impact factor: 12.479

Review 4.  Strategies and techniques to enhance the in situ endothelialization of small-diameter biodegradable polymeric vascular grafts.

Authors:  Anthony J Melchiorri; Narutoshi Hibino; John P Fisher
Journal:  Tissue Eng Part B Rev       Date:  2013-02-13       Impact factor: 6.389

5.  An in vivo study on endothelialized vascular grafts produced by autologous biotubes and adipose stem cells (ADSCs).

Authors:  Yu Chieh Tseng; Jun Neng Roan; Ying Chiang Ho; Chih Chan Lin; Ming Long Yeh
Journal:  J Mater Sci Mater Med       Date:  2017-09-15       Impact factor: 3.896

Review 6.  Small-diameter vascular tissue engineering.

Authors:  Dawit G Seifu; Agung Purnama; Kibret Mequanint; Diego Mantovani
Journal:  Nat Rev Cardiol       Date:  2013-05-21       Impact factor: 32.419

7.  Phthalimide neovascular factor 1 (PNF1) modulates MT1-MMP activity in human microvascular endothelial cells.

Authors:  Kristen A Wieghaus; Erwin P Gianchandani; Rebekah A Neal; Mikell A Paige; Milton L Brown; Jason A Papin; Edward A Botchwey
Journal:  Biotechnol Bioeng       Date:  2009-07-01       Impact factor: 4.530

8.  Surface Modification with NGF-Loaded Chitosan/Heparin Nanoparticles for Improving Biocompatibility of Cardiovascular Stent.

Authors:  Haixin Song; Tao Wu; Xiaotian Yang; Yangzheng Li; Ye Ye; Bo Li; Tao Liu; Shihui Liu; Jianhua Li
Journal:  Stem Cells Int       Date:  2021-04-24       Impact factor: 5.443

Review 9.  Extracellular matrix-based biomaterials for cardiac regeneration and repair.

Authors:  Haotong Li; Minghui Bao; Yu Nie
Journal:  Heart Fail Rev       Date:  2021-09       Impact factor: 4.214

10.  Radiological assessment of bioengineered bone in a muscle flap for the reconstruction of critical-size mandibular defect.

Authors:  Randa Al-Fotawei; Ashraf F Ayoub; Neil Heath; Kurt B Naudi; K Elizabeth Tanner; Matthew J Dalby; Jeremy McMahon
Journal:  PLoS One       Date:  2014-09-16       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.